Stemedica Cell Technologies, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of progenitor cell and protein therapeutics for underserved medical conditions. Stemedica has developed a proprietary manufacturing technology platform that produces allogeneic progenitor cell products with intellectual property protection under a low-oxygen, low-tension environment in a cGMP-compliant manufacturing facility. The company's lead drug candidate, ischemia-tolerant mesenchymal stem cells, or itMSCs, is an allogeneic progenitor cell therapy currently in clinical development for the treatment of ischemic stroke and Alzheimer’s disease. The company’s second drug candidate, ischemia-tolerant neural progenitor cells, or itNSCs, is an allogeneic cell therapy currently in development for spinal cord injury. In addition, Stemedica is developing progenitor multi-cell therapy (itMSCs and itNSCs) for ischemic stroke and progenitor cell and protein combination therapy for Alzheimer’s disease. More information on Stemedica may be found at www.stemedica.com.
Company Details
- Employees
- 32
- Founded
- -
- Address
- San Diego, Ca 92121, Us
- Phone
- 858-658-0910
- In****@****ica.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- stemedica.com
- HQ
- San Diego, CA
Stemedica Cell Technologies, Inc Questions
Stemedica Cell Technologies, Inc's helpline number is 858-658-0910
Stemedica Cell Technologies, Inc's website is stemedica.com
Stemedica Cell Technologies, Inc's LinkedIn profile is https://www.linkedin.com/company/stemedica-cell-technologies-inc
Stemedica Cell Technologies, Inc has
32 employees.
View email and phone details for 32
employees at Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc's industry is
Biotechnology Research
Stemedica Cell Technologies, Inc's top competitors are
Stemprotein, Llc.,
Cemvita Inc.,
Mirati Therapeutics,
Artiva Biotherapeutics,
Viracorp,
Dermal Essence,
Shoreline Biosciences, Inc.,
Abzena,
Native Digital Dna,
Poseida Therapeutics, Inc..
Stemedica Cell Technologies, Inc's support email address is Info@Stemedica.com
Stemedica Cell Technologies, Inc's categories are Biotechnology Research
Stemedica Cell Technologies, Inc's founding year is 2005
